Advertisement

Topics

Update: FDA Clears the Way to Approval for Novartis’ Key Competitor in CAR-T Race

11:08 EDT 8 Aug 2017 | Labiotech.eu

UPDATE 08/08/2017: The FDA has cleared Kite to skip the outside advisors hearing in the approval process, signaling that Novartis’ main competitor may launch its CAR-T  therapy as early as September — around the same time the Swiss pharma is ...

This awesome article Update: FDA Clears the Way to Approval for Novartis’ Key Competitor in CAR-T Race appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Update: FDA Clears the Way to Approval for Novartis’ Key Competitor in CAR-T Race

NEXT ARTICLE

More From BioPortfolio on "Update: FDA Clears the Way to Approval for Novartis’ Key Competitor in CAR-T Race"

Quick Search
Advertisement
 

Relevant Topics

Hearing
Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...